InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Kiener Peter A, 董事. Officer active across 1 company, notably Cue Biopharma, Inc.. In total, 2 filings have been logged. Activity tracked since 15 November 2021. The latest transaction was filed on 23 March 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Peter A. Kiener is a Board Member of Cue Biopharma, Inc. He brings his expertise to the board, contributing to strategic decision-making for the company. His experience in the biopharmaceutical sector is valuable for guiding management.